Skip to content
PICO Portalanswers from OpenAlex

Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage

PaperCitations, authors & open-access status

Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage is a paper indexed in PICO Portal from OpenAlex.

How many citations does Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage have?

PICO Portalcitation count

Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage has 0 citations in the OpenAlex counts PICO Portal stores.

When was Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage published?

PICO Portalyear

Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage has 2025 year in the PICO Portal index.

What is the open-access status of Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage?

PICO Portaloa status

Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage has closed oa status in the PICO Portal index.

What is the DOI of Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage?

PICO Portaldoi

The DOI for Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage is on the source record.

What is the PMID of Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage?

PICO Portalpmid

The PMID for Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage is on the source record.

What is the OpenAlex record for Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage?

PICO Portalopenalex

The OpenAlex for Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial